دورية أكاديمية

Fluxomic evidence for impaired contribution of short-chain acyl-CoA dehydrogenase to mitochondrial palmitate β-oxidation in symptomatic patients with ACADS gene susceptibility variants

التفاصيل البيبلوغرافية
العنوان: Fluxomic evidence for impaired contribution of short-chain acyl-CoA dehydrogenase to mitochondrial palmitate β-oxidation in symptomatic patients with ACADS gene susceptibility variants
المؤلفون: Dessein, Anne-Frédérique, Fontaine, Monique, Joncquel-Chevalier Curt, Marie, Briand, Gilbert, Sechter, Claire, Mention-Mulliez, Karine, Dobbelaere, Dries, Douillard, Claire, Lacour, Arnaud, Redonnet-Vernhet, Isabelle, Lamireau, Delphine, Barth, Magalie, Minot-Myhié, Marie-Christine, Kuster, Alice, de Lonlay, Pascale, Gregersen, Niels, Acquaviva, Cécile, Vianey-Saban, Christine, Vamecq, Joseph
المصدر: Dessein , A-F , Fontaine , M , Joncquel-Chevalier Curt , M , Briand , G , Sechter , C , Mention-Mulliez , K , Dobbelaere , D , Douillard , C , Lacour , A , Redonnet-Vernhet , I , Lamireau , D , Barth , M , Minot-Myhié , M-C , Kuster , A , de Lonlay , P , Gregersen , N , Acquaviva , C , Vianey-Saban , C & Vamecq , J 2017 , ' Fluxomic evidence for impaired contribution of short-chain acyl-CoA dehydrogenase to mitochondrial palmitate β-oxidation in symptomatic patients with ACADS gene ....
سنة النشر: 2017
المجموعة: Aarhus University: Research
مصطلحات موضوعية: Journal Article
الوصف: BACKGROUND: Despite ACADS (acyl-CoA dehydrogenase, short-chain) gene susceptibility variants (c.511C>T and c.625G>A) are considered to be non-pathogenic, encoded proteins are known to exhibit altered kinetics. Whether or not, they might affect overall fatty acid β-oxidation still remains, however, unclear. METHODS: De novo biosynthesis of acylcarnitines by whole blood samples incubated with deuterated palmitate (16-(2)H3,15-(2)H2-palmitate) is suitable as a fluxomic exploration to distinguish between normal and disrupted β-oxidation, abnormal profiles and ratios of acylcarnitines with different chain-lengths being indicative of the site for enzymatic blockade. Determinations in 301 control subjects of ratios between deuterated butyrylcarnitine and sum of deuterated C2 to C14 acylcarnitines served here as reference values to state specifically functional SCAD impairment in patients addressed for clinical and/or biological suspicion of a β-oxidation disorder. RESULTS: Functional SCAD impairment was found in 39 patients. The 27 patients accepting subsequent gene studies were all positive for ACADS mutations. Twenty-six of 27 patients were positive for c.625G>A variant. Twenty-three of 27 patients harbored susceptibility variants as sole ACADS alterations (18 homozygous and 3 heterozygous for c.625G>A, 2 compound heterozygous for c.625G>A/c.511C>T). CONCLUSION: Our present fluxomic assessment of SCAD suggests a link between ACADS susceptibility variants and abnormal β-oxidation consistent with known altered kinetics of these variants.
نوع الوثيقة: article in journal/newspaper
اللغة: English
العلاقة: https://pure.au.dk/portal/en/publications/2badf1b2-a7aa-4199-9e6a-9cf7ba21e67aTest
DOI: 10.1016/j.cca.2017.05.026
الإتاحة: https://doi.org/10.1016/j.cca.2017.05.026Test
https://pure.au.dk/portal/en/publications/2badf1b2-a7aa-4199-9e6a-9cf7ba21e67aTest
حقوق: info:eu-repo/semantics/restrictedAccess
رقم الانضمام: edsbas.42E262C2
قاعدة البيانات: BASE